Outcome of very preterm infants with Mycoplasma/Ureaplasma airway colonization treated with josamycine.
See
H
H
NICU, INSERM, AP-HP, Hôpital Robert Debré and Université Paris 7, Paris, France.
Lachenaud
J
J
Alberti
C
C
Mariani-Kurkdjian
P
P
Aujard
Y
Y
Baud
O
O
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000188:drug therapy* / Q000382:microbiology; D018445:Infectious Disease Transmission, Vertical; D015570:Josamycin / Q000627:therapeutic use*; D009175:Mycoplasma Infections / Q000188:drug therapy* / Q000382:microbiology; D019535:Mycoplasma hominis / Q000254:growth & development / Q000472:pathogenicity; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000382:microbiology; D016896:Treatment Outcome; D016869:Ureaplasma Infections / Q000188:drug therapy* / Q000382:microbiology; D016990:Ureaplasma urealyticum / Q000254:growth & development / Q000472:pathogenicity; D014621:Vagina / Q000382:microbiology
D000900:Anti-Bacterial Agents; D015570:Josamycin